| HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness AD Paltiel, KA Freedberg, CA Scott, BR Schackman, E Losina, B Wang, ... Clinical Infectious Diseases 48 (6), 806-815, 2009 | 313 | 2009 |
| The “ART” of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa E Losina, IV Bassett, J Giddy, S Chetty, S Regan, RP Walensky, D Ross, ... PloS one 5 (3), e9538, 2010 | 244 | 2010 |
| The cost-effectiveness of HLA-B* 5701 genetic screening to guide initial antiretroviral therapy for HIV BR Schackman, CA Scott, RP Walensky, E Losina, KA Freedberg, PE Sax Aids 22 (15), 2025-2033, 2008 | 164 | 2008 |
| Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC RP Walensky, A David Paltiel, E Losina, BL Morris, CA Scott, ER Rhode, ... Clinical Infectious Diseases 51 (4), 392-400, 2010 | 129 | 2010 |
| The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women RP Walensky, JE Park, R Wood, KA Freedberg, CA Scott, LG Bekker, ... Clinical Infectious Diseases 54 (10), 1504-1513, 2012 | 105 | 2012 |
| Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy KA Freedberg, N Kumarasamy, E Losina, AJ Cecelia, CA Scott, N Divi, ... Aids 21, S117-S128, 2007 | 83 | 2007 |
| Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India MA Bender, N Kumarasamy, KH Mayer, B Wang, RP Walensky, ... Clinical infectious diseases 50 (3), 416-425, 2010 | 68 | 2010 |
| The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa JH Levison, R Wood, CA Scott, AL Ciaranello, NA Martinson, C Rusu, ... Clinical infectious diseases 56 (4), 587-597, 2013 | 47 | 2013 |
| Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial BR Schackman, CA Scott, PE Sax, E Losina, TJ Wilkin, JE McKinnon, ... Clinical infectious diseases 45 (8), 1062-1070, 2007 | 44 | 2007 |
| Accelerating the delivery of cancer care at home during the Covid-19 pandemic AI Laughlin, M Begley, T Delaney, L Zinck, LM Schuchter, J Doyle, ... NEJM Catalyst Innovations in Care Delivery 1 (4), 2020 | 43 | 2020 |
| Meeting human resources for health staffing goals by 2018: a quantitative analysis of policy options in Zambia A Tjoa, M Kapihya, M Libetwa, K Schroder, C Scott, J Lee, E McCarthy Human Resources for Health 8, 1-10, 2010 | 40 | 2010 |
| The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial BR Schackman, LR Metsch, GN Colfax, JA Leff, A Wong, CA Scott, ... Drug and alcohol dependence 128 (1-2), 90-97, 2013 | 38 | 2013 |
| The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis MT Pho, S Swaminathan, N Kumarasamy, E Losina, C Ponnuraja, ... PloS one 7 (4), e36001, 2012 | 35 | 2012 |
| Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study CA Scott, HS Iyer, K McCoy, C Moyo, L Long, BA Larson, S Rosen BMC Public Health 14, 1-11, 2014 | 33 | 2014 |
| Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia CA Scott, AK Yeshiwondim, B Serda, C Guinovart, BH Tesfay, A Agmas, ... Malaria journal 15, 1-13, 2016 | 26 | 2016 |
| Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis CA Scott, H Iyer, DL Bwalya, K McCoy, G Meyer-Rath, C Moyo, ... PloS one 8 (6), e67910, 2013 | 26 | 2013 |
| Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis X Anglaret, CA Scott, RP Walensky, E Ouattara, E Losina, R Moh, ... Antiviral therapy 18 (1), 45-55, 2013 | 21 | 2013 |
| Mass testing and treatment for malaria followed by weekly fever screening, testing and treatment in Northern Senegal: feasibility, cost and impact RO Conner, Y Dieye, M Hainsworth, A Tall, B Cissé, F Faye, MD Sy, A Ba, ... Malaria journal 19, 1-15, 2020 | 19 | 2020 |
| Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia CA Scott, HS Iyer, D Lembela Bwalya, M Bweupe, SB Rosen, N Scott, ... PLoS One 8 (8), e72444, 2013 | 18 | 2013 |
| A framework for evaluating the costs of malaria elimination interventions: an application to reactive case detection in Southern Province of Zambia, 2014 BA Larson, T Ngoma, K Silumbe, MRI Rutagwera, B Hamainza, ... Malaria Journal 15, 1-15, 2016 | 16 | 2016 |
